FIELD: medicine.
SUBSTANCE: inventions relates to medicine, in particular to surgery, and concerns disintoxication of organism at surgical treatment of patients with invasive cancer of urinary bladder. With this purpose pre-operation and post-operation intramuscular introduction of sodium salt of 5-amino-1,2,3,4-tetrahydroftalazine-1,4-dione (galavite) is carried out. Introduction is performed intramuscularly, daily in doze 0.1 g. Before operation 5 injections are made. After operation 5 injections are made, and then 10 injections every second day in the same doze.
EFFECT: due to claimed procedure of said medication introduction method ensures faster ending of catabolic phase of post-operation period with absence of side effect in patients with III-IV stage of disease.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ORGANISM DISINTOXICATION IN SURGERY OF LOCALLY ADVANCED HYPERNEPHROID CANCER | 2006 |
|
RU2370264C2 |
| PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
| METHOD OF DIAGNOSING STAGE OF URINARY BLADDER CANCER INVASION | 2010 |
|
RU2454181C1 |
| METHOD FOR TREATMENT OF BILIARY PERITONITIS | 2004 |
|
RU2285522C2 |
| METHOD FOR COMBINATION THERAPY OF BENIGN PROSTATIC HYPERPLASIA OF LARGE DIMENSIONS IN AGED PATIENTS OR PATIENTS WITH MARKED INTERCURRENT PATHOLOGY | 2015 |
|
RU2585431C1 |
| METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
| METHOD FOR TREATING COMPLICATED FORMS OF URINARY BLADDER CANCER | 2003 |
|
RU2257856C1 |
| IMMUNOMODULATING AGENT | 1997 |
|
RU2113222C1 |
| METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
| METHOD OF CHEMOTHERAPY AT BLADDER CANCER | 2007 |
|
RU2352340C1 |
